Literature DB >> 18755348

Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans.

Jordan D Miller1, Yi Chu, Robert M Brooks, Wayne E Richenbacher, Ricardo Peña-Silva, Donald D Heistad.   

Abstract

OBJECTIVES: The aim of this study was to determine whether oxidative stress is increased in calcified, stenotic aortic valves and to examine mechanisms that might contribute to increased oxidative stress.
BACKGROUND: Oxidative stress is increased in atherosclerotic lesions and might play an important role in plaque progression and calcification. The role of oxidative stress in valve disease is not clear.
METHODS: Superoxide (dihydroethidium fluorescence and lucigenin-enhanced chemiluminescence), hydrogen peroxide H2O2 (dichlorofluorescein fluorescence), and expression and activity of pro- and anti-oxidant enzymes were measured in normal valves from hearts not suitable for transplantation and stenotic aortic valves that were removed during surgical replacement of the valve.
RESULTS: In normal valves, superoxide levels were relatively low and distributed homogeneously throughout the valve. In stenotic valves, superoxide levels were increased 2-fold near the calcified regions of the valve (p < 0.05); noncalcified regions did not differ significantly from normal valves. Hydrogen peroxide levels were also markedly elevated in calcified regions of stenotic valves. Nicotinamide adenine dinucleotide phosphate oxidase activity was not increased in calcified regions of stenotic valves. Superoxide levels in stenotic valves were significantly reduced by inhibition of nitric oxide synthases (NOS), which suggests uncoupling of the enzyme. Antioxidant mechanisms were reduced in calcified regions of the aortic valve, because total superoxide dismutase (SOD) activity and expression of all 3 SOD isoforms was significantly decreased. Catalase expression also was reduced in pericalcific regions.
CONCLUSIONS: This study provides the first evidence that oxidative stress is increased in calcified regions of stenotic aortic valves from humans. Increased oxidative stress is due at least in part to reduction in expression and activity of antioxidant enzymes and perhaps to uncoupled NOS activity. Thus, mechanisms of oxidative stress differ greatly between stenotic aortic valves and atherosclerotic arteries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755348      PMCID: PMC2748760          DOI: 10.1016/j.jacc.2008.05.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  50 in total

1.  Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.

Authors:  Nalini M Rajamannan; Malayannan Subramaniam; Frank Caira; Stuart R Stock; Thomas C Spelsberg
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

2.  Age-associated aortic stenosis in apolipoprotein E-deficient mice.

Authors:  Kimie Tanaka; Masataka Sata; Daiju Fukuda; Yoshihiro Suematsu; Noboru Motomura; Shinichi Takamoto; Yasunobu Hirata; Ryozo Nagai
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

3.  Identification and characterization of calcifying valve cells from human and canine aortic valves.

Authors:  E R Mohler; M K Chawla; A W Chang; N Vyavahare; R J Levy; L Graham; F H Gannon
Journal:  J Heart Valve Dis       Date:  1999-05

4.  Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E.

Authors:  Hong Yang; L Jackson Roberts; Ming Jian Shi; Li Chun Zhou; Billy R Ballard; Arlan Richardson; Zhong Mao Guo
Journal:  Circ Res       Date:  2004-11-04       Impact factor: 17.367

5.  Angiotensin-converting enzyme inhibitors and change in aortic valve calcium.

Authors:  Kevin D O'Brien; Jeffrey L Probstfield; Michael T Caulfield; Khurram Nasir; Junichiro Takasu; David M Shavelle; Audrey H Wu; Xue-Qiao Zhao; Matthew J Budoff
Journal:  Arch Intern Med       Date:  2005-04-25

6.  Electron microscopic observations of apoptotic cells in various etiologies of human cardiovascular diseases.

Authors:  Y S Lee; Y Y Chou
Journal:  Chin Med J (Engl)       Date:  1998-05       Impact factor: 2.628

7.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.

Authors:  S Joanna Cowell; David E Newby; Robin J Prescott; Peter Bloomfield; John Reid; David B Northridge; Nicholas A Boon
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

8.  Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function.

Authors:  S Milstien; Z Katusic
Journal:  Biochem Biophys Res Commun       Date:  1999-10-05       Impact factor: 3.575

Review 9.  ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

10.  p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy.

Authors:  M Ushio-Fukai; R W Alexander; M Akers; K K Griendling
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

View more
  125 in total

Review 1.  The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.

Authors:  Sammy Elmariah; Emile R Mohler
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

2.  Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis.

Authors:  Su-Li Cheng; Jian-Su Shao; Linda R Halstead; Kathryn Distelhorst; Oscar Sierra; Dwight A Towler
Journal:  Circ Res       Date:  2010-05-20       Impact factor: 17.367

3.  Transcriptional and phenotypic changes in aorta and aortic valve with aging and MnSOD deficiency in mice.

Authors:  Carolyn M Roos; Michael Hagler; Bin Zhang; Elise A Oehler; Arman Arghami; Jordan D Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-30       Impact factor: 4.733

4.  Differential proteoglycan and hyaluronan distribution in calcified aortic valves.

Authors:  Elizabeth H Stephens; Jerome G Saltarrelli; L Scott Baggett; Indrajit Nandi; Joyce J Kuo; Alan R Davis; Elizabeth A Olmsted-Davis; Michael J Reardon; Joel D Morrisett; Kathryn Jane Grande-Allen
Journal:  Cardiovasc Pathol       Date:  2010-12-24       Impact factor: 2.185

Review 5.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

Review 6.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

7.  Growth and maturation of heart valves leads to changes in endothelial cell distribution, impaired function, decreased metabolism and reduced cell proliferation.

Authors:  Lindsey J Anstine; Chris Bobba; Samir Ghadiali; Joy Lincoln
Journal:  J Mol Cell Cardiol       Date:  2016-10-15       Impact factor: 5.000

8.  Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling.

Authors:  Jennifer Richards; Ismail El-Hamamsy; Si Chen; Zubair Sarang; Padmini Sarathchandra; Magdi H Yacoub; Adrian H Chester; Jonathan T Butcher
Journal:  Am J Pathol       Date:  2013-03-13       Impact factor: 4.307

9.  Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.

Authors:  Kevin Bosse; Chetan P Hans; Ning Zhao; Sara N Koenig; Nianyuan Huang; Anuradha Guggilam; Stephanie LaHaye; Ge Tao; Pamela A Lucchesi; Joy Lincoln; Brenda Lilly; Vidu Garg
Journal:  J Mol Cell Cardiol       Date:  2013-04-11       Impact factor: 5.000

10.  MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.

Authors:  Claudia Goettsch; Joshua D Hutcheson; Elena Aikawa
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.